Darren Sherman - Jan 5, 2022 Form 4 Insider Report for Motus GI Holdings, Inc. (MOTS)

Role
Director
Signature
/s/ Andrew Taylor, power of attorney
Stock symbol
MOTS
Transactions as of
Jan 5, 2022
Transactions value $
$0
Form type
4
Date filed
1/7/2022, 03:45 PM
Next filing
Feb 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MOTS Common Stock, par value $0.0001 per share Award $0 +90.5K +86.97% $0.00 195K Jan 5, 2022 Direct F1
holding MOTS Common Stock, par value $0.0001 per share 2.05M Jan 5, 2022 By Orchestra BioMed, Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 5, 2022, Reporting Person was granted 90,521 shares of Common Stock as compensation in lieu of cash for Reporting Persons service as a director for calendar year 2022, pursuant to the Company's non-employee director compensation policy. The grant was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan").
F2 Reporting Person is a member of the board of directors of Orchestra BioMed, Inc., a Delaware corporation ("OBIO"). Reporting Person jointly exercises dispositive and voting power over the shares owned by OBIO. Reporting Person disclaims, for purposes of Section 16, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Reporting Person is the beneficial owners of such securities for purposes of Section 16 or for any other purposes.